Search
  • Nicole Ruggiero

Clostridium difficile vaccine development efforts

Dr. Killeen (CEO) will be presenting at Vaccines Research And Development, November 19, 2019, at the Crowne Plaza Boston.


12:10-12:35 Prophylactic and therapeutic vaccine approach targeting C. difficile infection and relapse. Kevin Killeen, Chief Scientific Officer, Matrivax R&D Corp



0 views

© 2019 Matrivax Research and Development Corporation

650 Albany Street, Suite 117, Boston, MA 02118

Tel: 617-3587640